Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Pfizer Inc (NYSE:PFE)

36.89
Delayed Data
As of Jul 29
 +0.22 / +0.60%
Today’s Change
28.25
Today|||52-Week Range
37.19
+14.28%
Year-to-Date
Jim Cramer's 'Mad Money' Recap: Here's What I'm Watching Next Week
Jul 29 / TheStreet.com - Paid Partner Content
Zacks Industry Outlook Highlights: Bristol-Myers, Pfizer, Sanofi, Amgen and Biogen
Jul 25 / Zacks.com - Paid Partner Content
Trade-Ideas: Pfizer (PFE) Is Today's Post-Market Leader Stock
Jul 29 / TheStreet.com - Paid Partner Content
Dividend Investors Should Research These 10 Stocks - July
Jul 25 / GuruFocus News - Paid Partner Content
Tech Lights the Way on Strong Earnings
Jul 29 / TheStreet.com - Paid Partner Content
Bloodlines: Rivals look to create 'off-the-shelf' treatment
Jul 24 / FT.com - Paid Partner Content
Pfizer (PFE) Likely to Beat Earnings in Q2 Again
Jul 29 / Zacks.com - Paid Partner Content
Pharma Industry Outlook: Fundamentals Remain Strong
Jul 22 / Zacks.com - Paid Partner Content
Buy Merck on Near-Term Weakness
Jul 29 / TheStreet.com - Paid Partner Content
Can You Guess Which Pharma Giant Spends $1 Billion-Plus a Year On Direct-To-Consumer ...
Jul 22 / MotleyFool.com - Paid Partner Content
3 Great Stocks For Retirees
Jul 29 / MotleyFool.com - Paid Partner Content
These 5 Healthcare Stocks Have Huge Dividend Yields -- Are Any Worth Buying?
Jul 21 / MotleyFool.com - Paid Partner Content
Better Buy: Regeneron Pharmaceuticals vs. Pfizer
Jul 29 / MotleyFool.com - Paid Partner Content
J&J (JNJ) Stock Gains on Q2 Earnings and Improved Outlook
Jul 19 / Zacks.com - Paid Partner Content
Sanofi Quarterly Earnings, Sales Slide, Reiterates Discipline on Medivation
Jul 29 / TheStreet.com - Paid Partner Content
5 Big Pharma Stocks Struggling to Raise Their Dividends
Jul 19 / MotleyFool.com - Paid Partner Content
Pfizer (PFE) Stock Down, Partners with Western Oncolytics on Cancer Technology
Jul 28 / TheStreet.com - Paid Partner Content
Roche's Gazyva Fails in Phase III B-cell Lymphoma Study
Jul 18 / Zacks.com - Paid Partner Content
3 Stocks Pushing The Health Care Sector Downward
Jul 28 / TheStreet.com - Paid Partner Content
Dow 30 Stock Roundup: JPM Q2 Impresses, Orders for Boeing & United Technologies
Jul 18 / Zacks.com - Paid Partner Content
Jim Cramer: Second-Quarter Earnings Have Been Mixed
Jul 28 / TheStreet.com - Paid Partner Content
Biosimilars set topple two of the world's biggest drug franchises
Jul 14 / FT.com - Paid Partner Content
Bristol-Myers (BMY) Beats on Q2 Earnings, Lifts Outlook
Jul 28 / Zacks.com - Paid Partner Content
Medivation: scarcity value
Jul 06 / FT.com - Paid Partner Content
Better Buy: Johnson & Johnson vs. Pfizer
Jul 28 / MotleyFool.com - Paid Partner Content
Medivation confident drugs pipeline will win over suitors
Jul 06 / FT.com - Paid Partner Content
Allergan Cures Its Ailing Chart
Jul 28 / TheStreet.com - Paid Partner Content
Medivation agrees to $10bn takeover talks
Jul 05 / FT.com - Paid Partner Content
5 Incredibly Cheap Big Pharma Stocks
Jul 25 / MotleyFool.com - Paid Partner Content